Related Experiment Video

Updated: Jul 5, 2026

Ex Situ Normothermic Machine Perfusion of Donor Livers
12:13

Ex Situ Normothermic Machine Perfusion of Donor Livers

Published on: May 26, 2015

Org-31806 Organon NV

D C Skinner1

  • 1Unite Neuroendocrinologie Sexuelle, Station Physiologie de Reproduction, Institut National de la Recherche Agronomique, F-37380 Nouzilly, France. skinner@tours.inra.fr

Idrugs : the Investigational Drugs Journal
|May 10, 2008
PubMed

Insights

Org-31806 is a progestogen antagonist drug being developed for cancer and menstruation disorders. This compound shows promise for treating hormone-related conditions.

Area of Science:

  • Pharmacology
  • Oncology
  • Gynecology

Background:

  • Progestogens play a role in various physiological processes and diseases.
  • Progestogen antagonists offer a therapeutic strategy for hormone-dependent conditions.

Purpose of the Study:

  • To introduce Org-31806, a novel progestogen antagonist.
  • To highlight its potential therapeutic applications in oncology and gynecology.

Main Methods:

  • Drug development pipeline analysis.
  • Review of preclinical and clinical data (if available).

Main Results:

  • Org-31806 is under development by Organon.
  • Demonstrates potential in preclinical models for cancer and menstruation disorders.

Conclusions:

  • Org-31806 represents a promising therapeutic candidate.
  • Further research is warranted to establish its efficacy and safety profile.

More Related Videos

The Organoid Reconstitution Assay (ORA) for the Functional Analysis of Intestinal Stem and Niche Cells09:38

The Organoid Reconstitution Assay (ORA) for the Functional Analysis of Intestinal Stem and Niche Cells

Published on: November 20, 2017

Related Concept Videos

Operons02:09

Operons

Prokaryotes can control gene expression through operons—DNA sequences consisting of regulatory elements and clustered, functionally related protein-coding genes. Operons use a single promoter sequence to initiate transcription of a gene cluster (i.e., a group of structural genes) into a single mRNA molecule. The terminator sequence ends transcription. An operator sequence, located between the promoter and structural genes, prohibits the operon’s transcriptional activity if bound by a repressor...
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Transgenic Organisms00:53

Transgenic Organisms

Overview
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...